Abstract A80: The effects of CCL3 on dendritic cell migration and immune cell activation

Glioblastoma (GBM) remains uniformly lethal and current therapy is ineffective and incapacitating. Standard therapies are limited by nonspecific toxicity, and the median overall survival for patients with GBM remains

Saved in:
Bibliographic Details
Published in:Cancer immunology research 2020-04, Vol.8 (4_Supplement), p.A80-A80
Main Authors: Schaller, Teilo H., Batich, Kristen A., Hotchkiss, Kelly, Cui, Xiuyu, Sanchez-Perez, Luis, Sampson, John H.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Glioblastoma (GBM) remains uniformly lethal and current therapy is ineffective and incapacitating. Standard therapies are limited by nonspecific toxicity, and the median overall survival for patients with GBM remains
ISSN:2326-6066
2326-6074
DOI:10.1158/2326-6074.TUMIMM18-A80